Increased level of Plasma Salusin-α and Salusin-β in patients with Multiple Sclerosis

CONCLUSION: In conclusion, we found that there was a relationship between salusin-α and salusin-β levels, and MS disease. Since RRMS is the first stage of MS and its most common type, it is important to perform biomarker studies in this period in terms of early planning of treatment. Although salusin-α and salusin-β levels increase in RRMS patients, further studies are needed to understand its relation with other neurological and inflammatory diseases to define it as a biomarker.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research